Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical trials for children].

J Boos1

  • 1Universitätsklinik, Münster. boosj@uni-muenster.de

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|May 12, 2005
PubMed
Summary
This summary is machine-generated.

New regulations facilitate pharmaceutical research for pediatric drug development. However, increased costs and complexities may limit future clinical studies on children's drug safety and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Quality assurance in CT: implementation of the updated national diagnostic reference levels using an automated CT dose monitoring system.

Clinical radiology·2018
Same author

Iterative metal artefact reduction in CT: can dedicated algorithms improve image quality after spinal instrumentation?

Clinical radiology·2017
Same author

Facet tropism and facet joint orientation: risk factors for the development of early biochemical alterations of lumbar intervertebral discs.

Osteoarthritis and cartilage·2016
Same author

Dose Monitoring in Radiology Departments: Status Quo and Future Perspectives.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2016
Same author

Asymmetrical flow field-flow fractionation for the analysis of PEG-asparaginase.

Talanta·2015

Area of Science:

  • Pediatric pharmacology
  • Drug development regulation
  • Clinical trial management

Context:

  • The 12th German Medicines Act (AMG) amendment and EU Directive 2001/20/EC established legal frameworks for pediatric drug studies.
  • This has created opportunities for the pharmaceutical industry to increase its involvement in developing medications for children.
  • Regulatory bodies like BfArM, EMEA, and FDA have formed expert committees to address pediatric drug approval.

Purpose:

  • To outline the implications of new legal guidelines on pediatric drug development.
  • To discuss the establishment of expert committees and enhanced pharmacovigilance measures.
  • To analyze the challenges and potential limitations posed by regulatory requirements on future clinical studies in children.

Summary:

Related Experiment Videos

  • New regulations provide a framework for pediatric drug development, encouraging pharmaceutical industry involvement.
  • Established expert committees and strengthened pharmacovigilance aim to improve drug safety and treatment standards for children.
  • Defined terms like 'sponsor responsibility' and 'trial approval' present challenges, potentially increasing costs and limiting the scope of future research.

    • Impact:

    • Potential for improved drug therapy and safety for children through increased research and development.
    • Risk of escalating costs and reduced research questions due to stringent regulatory requirements.
    • The need for a balanced approach to ensure children benefit from scientific progress without undue research limitations.